1991•PubMedRequires access

Imidazoles for vaginitis.

Lee Cr, McKenzie Ca, A Nobles

Open publisher page 1 citations

Abstract

Vaginal candidiasis is a common infection in women for which several effective therapeutic agents are currently available. Clotrimazole and miconazole were introduced in 1975, and both recently became available over the counter. These imidazole agents have largely replaced nystatin as primary therapy because of greater antifungal activity and shorter treatment regimens, thereby enhancing patient compliance. The cost for these OTC regimens ranges from $12.00 to $24.00 for the patient.

About this research paper

What this paper is about

Vaginal candidiasis is a common infection in women for which several effective therapeutic agents are currently available. Clotrimazole and miconazole were introduced in 1975, and both recently became available over the counter. These imidazole agents have largely replaced nystatin as primary therapy because of greater antifungal activity and shorter treatment regimens, thereby enhancing patient compliance. The cost for these OTC regimens ranges from $12.00 to $24.00 for the patient.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Vaginal candidiasis is a common infection in women for which several effective therapeutic agents are currently available. Clotrimazole and miconazole were introduced in 1975, and both recently became available over the counter. These imidazole agents have largely replaced nystatin as primary therapy because of greater antifungal activity and shorter treatment regimens, thereby enhancing patient compliance. The cost for these OTC regimens ranges from $12.00 to $24.00 for the patient.

Key concepts: Clotrimazole, Miconazole, Nystatin, Vaginitis, Medicine, Antifungal, Vulvovaginal Candidiasis, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Imidazoles for vaginitis. — Research Paper | ScholarLens